Inflammation and Coronary Endothelial Function
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 111 participants.
Also called NCT02366091
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose other
- Phase
- Phase 2
- Enrolled
- 111 participants
- Registry
-
NCT02366091
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02366091. Randomized; triple masking; primary purpose other. Start 2015-01 (actual); primary completion 2020-08-01 (actual). Results posted on 2021-10-21.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Inflammation and Coronary Endothelial Function
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Methotrexate
- Intervention (Drug)
- Colchicine
- Intervention (Drug)
- Placebo
- Lead sponsor
- Johns Hopkins University
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct02366091- Content hash
3c6a3137c7804d3d25b6a6547d0d918e7c642c18a65e04db874704681f903794